[17] FDA为执行细节向业界征询，但代表仿制药企业的美国仿制药协会(The Generic Pharmaceutical Association)，于代表专利药企业的美国药物研究与生产协会(The Pharmaceutical Research and Manufacturers of America)和生物产业组织(The B...
KathleenJaegerofAmerica'sGenericPharmaceuticalAssociationadds that brandedfirms try to extend their lucrative monopolies by filing less rigorous secondary patents designed “toblockgenerics”.